Clinical trial

Cell Therapy in Myocardial Infarction

NCT00350766 · Ministry of Health, Brazil, Other · Terminated

Key facts

NCT number NCT00350766
Title Cell Therapy in Myocardial Infarction
Official title Multicenter Prospective Randomized Double Blind Trial of Bone Marrow Mononuclear Cells Transplantation Through Intracoronary Injection in Patients With Acute Myocardial Infarction.
Acronym EMRTCC
Lead sponsor Ministry of Health, Brazil, Other
Collaborators Pro-Cardiaco Hospital Hospital do Coracao Instituto Estadual de Cardiologia Aloysio de Castro Hospital Cardiológico Costantini Hospital Universitário Regional do Norte do Paraná - FUEL Hospital Santa…
Status Terminated
Phase Phase 2/Phase 3
Study type Interventional
Conditions Acute Myocardial Infarction
Intervention type Procedure
Interventions Autologous Bone Marrow Mononuclear Cells (ABMMC) Transplantation
Enrollment 166
Start date Jul 1, 2006
Primary completion Jan 21, 2014
Completion Jul 14, 2014
First posted Jul 11, 2006
Last update posted Mar 30, 2017
Countries Brazil

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies